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Introduction {#jah31710-sec-0004}
============

Cardiovascular disease (CVD) is a leading cause of mortality among Hispanic/Latino adults in the United States. Although recent reports from the landmark Hispanic Community Health Study/Study of Latinos (HCHS/SOL) documented the substantial and pervasive burden of readily measurable major adverse CVD risk factors, marked variations in adverse CVD risk profiles among diverse Hispanic/Latino persons have also been noted, potentially related to their heterogeneous lifestyles, exposures, and acculturation to US society.[1](#jah31710-bib-0001){ref-type="ref"}

Large‐scale prospective cohort studies of non‐Hispanic/Latino young adult and middle‐aged men and women with decades of follow‐up have demonstrated multiple beneficial outcomes associated with favorable levels of all major CVD risk factors (ie, low risk \[LR\]).[2](#jah31710-bib-0002){ref-type="ref"}, [3](#jah31710-bib-0003){ref-type="ref"}, [4](#jah31710-bib-0004){ref-type="ref"}, [5](#jah31710-bib-0005){ref-type="ref"}, [6](#jah31710-bib-0006){ref-type="ref"}, [7](#jah31710-bib-0007){ref-type="ref"} LR status in young adulthood or middle age is associated with markedly lower age‐specific CVD and total mortality rates, higher life expectancies, lower health care costs, and better quality of life at older ages.[2](#jah31710-bib-0002){ref-type="ref"}, [3](#jah31710-bib-0003){ref-type="ref"}, [4](#jah31710-bib-0004){ref-type="ref"}, [5](#jah31710-bib-0005){ref-type="ref"}, [6](#jah31710-bib-0006){ref-type="ref"}, [7](#jah31710-bib-0007){ref-type="ref"} The importance of population‐wide LR status to overcome the CVD epidemic is now widely accepted, with LR status forming the basis of the ideal cardiovascular health construct described in the American Heart Association (AHA) 2020 Impact Goal.[8](#jah31710-bib-0008){ref-type="ref"} According to national data, the prevalence of LR was ≈8.2% among non‐Hispanic white US adults (and 7.5% overall) in 1999--2004.[9](#jah31710-bib-0009){ref-type="ref"}

Previous studies included few Hispanic/Latino participants,[2](#jah31710-bib-0002){ref-type="ref"}, [3](#jah31710-bib-0003){ref-type="ref"}, [4](#jah31710-bib-0004){ref-type="ref"}, [5](#jah31710-bib-0005){ref-type="ref"}, [6](#jah31710-bib-0006){ref-type="ref"}, [7](#jah31710-bib-0007){ref-type="ref"} and existing estimates of prevalence of LR status among US Hispanics/Latino adults based on national survey data are limited mostly to those of Mexican American heritage.[9](#jah31710-bib-0009){ref-type="ref"} Furthermore, there are no data on associations of low CVD risk status with acculturation among Hispanic/Latino adults from diverse backgrounds. Comprehensive and current data on the cardiovascular health of diverse US Hispanic/Latino groups, including not only the well‐known burden of adverse risk but also the less‐documented prevalence of favorable risk status, is critically important for the development of tailored individual‐ and population‐level interventions to prevent future CVD in this rapidly growing segment of the US population.

This paper describes the age‐, sex‐, and Hispanic/Latino background--specific prevalence of LR profile among diverse US Hispanic/Latino adults free of clinical CVD and examines the associations of LR profile with measures of acculturation using data from HCHS/SOL.

Methods {#jah31710-sec-0005}
=======

Study Design and Population {#jah31710-sec-0006}
---------------------------

HCHS/SOL is a population‐based cohort study designed to examine risk and protective factors for chronic diseases among US Hispanic/Latino adults and to quantify morbidity and mortality prospectively. Details of the sampling methods and design have been published.[10](#jah31710-bib-0010){ref-type="ref"}, [11](#jah31710-bib-0011){ref-type="ref"} Briefly, between March 2008 and June 2011, 16 415 self‐identified Hispanic/Latino adults aged 18 to 74 years were recruited from randomly selected households in 4 US communities (Bronx, NY; Chicago, IL; Miami, FL; San Diego, CA), using a stratified 2‐stage probability sample design.[10](#jah31710-bib-0010){ref-type="ref"} Participants included adults with Cuban, Dominican, Mexican, Puerto Rican, and Central and South American backgrounds. The study was approved by the institutional review board at each center, and written informed consent was obtained from all participants.

Examination Methods {#jah31710-sec-0007}
-------------------

Participants were asked to fast and to refrain from smoking for 12 hours prior to the examination and to avoid vigorous physical activity the morning of the visit. Information was obtained using questionnaires on demographic factors, socioeconomic status, cigarette smoking, physical activity (moderate/heavy intensity work and leisure activities in a typical week), and medical history and the Short Acculturation Scale for Hispanics (SASH),[12](#jah31710-bib-0012){ref-type="ref"} which includes social and language subscales and proxy measures of acculturation (including nativity, duration of residence in the United States, generational status, language preference, and age at immigration). Participants were instructed to bring all medications they had taken in the past month.

Height was measured to the nearest centimeter and body weight to the nearest 0.1 kg. Body mass index (BMI) was computed as weight divided by height squared (kg/m^2^). Following a 5‐minute rest period, 3 seated blood pressure (BP) measurements were obtained using an automatic sphygmomanometer; the second and third readings were averaged. Blood samples were collected and shipped to a central laboratory for analysis according to standardized protocols. Blind replicate measurements were conducted for 5% of the samples. Details of the quality control procedures implemented have been described previously.[11](#jah31710-bib-0011){ref-type="ref"} Total serum cholesterol was measured using a cholesterol oxidase enzymatic method, and high‐density lipoprotein cholesterol was measured using a direct magnesium/dextran sulfate method. Plasma glucose was measured using a hexokinase enzymatic method (Roche Diagnostics Corp). Low‐density lipoprotein cholesterol was calculated using the Friedewald equation.[13](#jah31710-bib-0013){ref-type="ref"} Hemoglobin A1c was measured using the Tosoh G7 Automated HPLC Analyzer (Tosoh Bioscience Inc).

Definition of Risk Factors {#jah31710-sec-0008}
--------------------------

Favorable levels of major CVD risk factors were defined based on national guidelines.[14](#jah31710-bib-0014){ref-type="ref"}, [15](#jah31710-bib-0015){ref-type="ref"}, [16](#jah31710-bib-0016){ref-type="ref"}, [17](#jah31710-bib-0017){ref-type="ref"} LR status was defined as having all of the following factors: serum total cholesterol \<200 mg/dL and not taking cholesterol‐lowering medication; systolic BP \<120 mm Hg, diastolic BP \<80 mm Hg, and not taking antihypertensive medication; BMI \<25; not currently smoking; and fasting glucose \<100 mg/dL, hemoglobin A1c \<5.7%, not taking medication for diabetes mellitus, and no history of diabetes mellitus.

Unfavorable or borderline risk factor levels were defined as total cholesterol 200 to 239 mg/dL and not taking cholesterol‐lowering medications; systolic BP 121 to 139 mm Hg or diastolic BP 81 to 89 mm Hg and not taking antihypertension medication; fasting glucose 100 to 125.9 mg/dL or hemoglobin A1c 5.7% to 6.4%, not taking medication for diabetes mellitus, and no history of diabetes mellitus; and BMI 25.0 to 29.9. Adverse CVD risk factors were defined as serum cholesterol ≥240 mg/dL or taking cholesterol‐lowering medication; systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or taking antihypertensive medication; BMI ≥30.0; fasting glucose ≥126 mg/dL, hemoglobin A1c ≥6.5%, or taking medication for diabetes mellitus; and current cigarette smoking. Participants not at LR were classified as having no adverse but ≥1 unfavorable or borderline risk factor, any single adverse risk factor, or ≥2 adverse risk factors. Of note, smoking status was dichotomized as not currently smoking (LR) versus current smoking (adverse), consistent with both previous research on low CVD risk profile[3](#jah31710-bib-0003){ref-type="ref"}, [6](#jah31710-bib-0006){ref-type="ref"} and the AHA\'s definition of cardiovascular health metrics[8](#jah31710-bib-0008){ref-type="ref"} included in the ideal cardiovascular health construct (designed to be simple and accessible by the public and by health practitioners and to represent actionable items to improve cardiovascular health). Participants classified as having no adverse but ≥1 unfavorable or borderline risk factor were, by definition, not current smokers.

Statistical Analyses {#jah31710-sec-0009}
--------------------

Reported values for mean, prevalence, and odds ratio were weighted to adjust for sampling probability and nonresponse.[10](#jah31710-bib-0010){ref-type="ref"}, [11](#jah31710-bib-0011){ref-type="ref"} All analyses were conducted for men and women separately. Age‐adjusted LR prevalence was calculated by Hispanic/Latino background for all participants and stratified by age groups (18--44 years that is young adults, and 45--74 years that is middle‐aged and older adults). Prevalence of LR age‐standardized to the 2010 US population was also calculated. Logistic regression analyses, adjusted for age and education, were used to examine associations of LR profile (compared with not LR) with SASH scores and proxy measures of acculturation. Analyses adjusted for family history of coronary heart disease, income, health insurance status, Hispanic/Latino background, and field center were also conducted. Additional sensitivity analyses were conducted to examine age‐adjusted association of LR status with measures of acculturation across strata of educational attainment. Odds ratios with 95% CIs were computed.

Age‐adjusted descriptive characteristics were computed for LR participants and compared with those with unfavorable or adverse CVD risk status. Differences between groups were tested using chi‐square tests for categorical variables and F tests for continuous variables. All analyses were performed using survey‐specific procedures to account for the multistage sampling design, stratification, and clustering in SAS version 9.3 (SAS Institute) and SUDAAN release 10.0.0 (Research Triangle Institute).

Exclusions {#jah31710-sec-0010}
----------

Of the 16 415 HCHS/SOL participants, 1658 were excluded from these analyses for the following reasons: missing data on total cholesterol (n=134), BMI (n=53), cigarette smoking (n=35), or other covariates (n=481); electrocardiographic evidence of past myocardial infarction (n=360); baseline age ≥75 years (n=5); or lack of self‐identification as any of the 6 aforementioned Hispanic/Latino backgrounds (n=590). Consequently, these analyses included data from 14 757 participants (5810 men and 8947 women).

Results {#jah31710-sec-0011}
=======

Characteristics of the Study Cohort {#jah31710-sec-0012}
-----------------------------------

The mean age of the participants was 41.3 years, and 60.6% were women. Overall, 32.7% of the sample had less than a high school education, 49.8% were married or living with a partner, and 71.2% had lived in the United States for ≥10 years. Spanish was the preferred language for the majority of participants (76.5%), and 49.7% had some health insurance (data not shown).

Prevalence of LR Status and Individual Favorable Risk Factors {#jah31710-sec-0013}
-------------------------------------------------------------

The prevalence of LR status by Hispanic/Latino background is depicted for all participants in Table [1](#jah31710-tbl-0001){ref-type="table-wrap"} and for men and women in [Figure](#jah31710-fig-0001){ref-type="fig"} --- Panel A and B, respectively. Among HCHS/SOL participants, the overall age‐adjusted prevalence of LR status was 8.4%. Among both sexes and all Hispanic/Latino backgrounds, LR status was uniformly rare. Among men, overall age‐adjusted LR prevalence was 5.1%, whereas LR prevalence age‐standardized to the 2010 US population was 4.9% (Table [1](#jah31710-tbl-0001){ref-type="table-wrap"}); age‐adjusted LR prevalence ranged from 4.2% (Mexican men) to 7.2% (Central American men) (Table [1](#jah31710-tbl-0001){ref-type="table-wrap"} and [Figure](#jah31710-fig-0001){ref-type="fig"} --- Panel A). Adjustment for educational attainment, duration of residence in the United States, health insurance status (Table [1](#jah31710-tbl-0001){ref-type="table-wrap"}), or language preference (data not shown) did not appreciably alter the findings. Among men aged 18 to 44 years, LR prevalence averaged 8.1% overall and ranged from 7.2% (Mexican) to 10.7% (South American); among men aged 45 to 74 years, LR prevalence averaged 1.4% (range 0.6--1.6%) (Table [2](#jah31710-tbl-0002){ref-type="table-wrap"}) (Table S1 provides the numbers of participants used to calculate weighted prevalence in Table [2](#jah31710-tbl-0002){ref-type="table-wrap"}).

###### 

Adjusted Prevalence of Low CVD Risk Status by Sex and Hispanic/Latino Background

  Prevalence of Low CVD Risk Status[a](#jah31710-note-0003){ref-type="fn"}, [b](#jah31710-note-0004){ref-type="fn"}   Hispanic/Latino Background                                                                                                                      
  ------------------------------------------------------------------------------------------------------------------- ---------------------------- ------------------- ------------------ ------------------ ----------------- ------------------ ------------------- ----------
  All participants                                                                                                                                                                                                                                                    
  Participants, n                                                                                                     14 757                       2238                1369               6035               2481              1624               1010                ---
  Age‐standardized[c](#jah31710-note-0005){ref-type="fn"}                                                             7.6 (6.8--8.3)               9.5 (7.7--11.3)     7.6 (6.0--9.2)     7.4 (6.2--8.6)     5.7 (4.3--7.1)    7.9 (6.1--9.7)     9.7 (7.0--12.3)     0.0176
  Age‐adjusted                                                                                                        8.4 (7.6--9.1)               10.4 (8.9--11.8)    8.0 (5.9--10.1)    7.7 (6.2--9.1)     6.8 (5.4--8.3)    8.6 (6.5--10.7)    10.2 (7.6--12.7)    0.0111
  Men                                                                                                                                                                                                                                                                 
  Participants, n                                                                                                     5810                         1040                473                2236               1019              629                413                 ---
  Age standardized[c](#jah31710-note-0005){ref-type="fn"}                                                             4.9 (4.1--5.7)               4.9 (3.1--6.8)      4.3 (2.3--6.3)     4.3 (3.0--5.6)     6.0 (4.0--8.1)    6.7 (3.7--9.7)     6.1 (3.4--8.8)      0.4741
  Adjusted for age                                                                                                    5.1 (4.2--6.0)               5.4 (3.8--7.0)      4.6 (2.1--7.0)     4.2 (2.7--5.8)     6.6 (4.3--8.8)    7.2 (3.6--10.7)    6.6 (3.5--9.7)      0.3853
  Adjusted for age, education                                                                                         5.1 (4.2--6.0)               5.3 (3.7--6.9)      4.6 (2.2--7.1)     4.3 (2.7--5.8)     6.6 (4.3--8.8)    7.3 (3.7--10.9)    6.5 (3.4--9.6)      0.3911
  Adjusted for age, education, years in US                                                                            5.1 (4.2--6.0)               5.4 (3.6--7.1)      4.5 (2.0--6.9)     4.3 (2.7--5.8)     6.5 (3.9--9.0)    7.4 (3.8--11.0)    6.2 (3.1--9.3)      0.4355
  Adjusted for age, education, years in US, health insurance                                                          5.3 (4.4--6.2)               5.8 (4.0--7.6)      4.4 (1.7--7.0)     4.5 (3.0--6.0)     6.2 (3.6--8.9)    7.8 (4.1--11.4)    6.5 (3.3--9.7)      0.4310
  Adjusted for age, education, years in US, health insurance, physical activity                                       5.5 (4.6--6.4)               5.8 (4.0--7.6)      4.5 (1.9--7.2)     4.7 (3.1--6.3)     6.6 (3.8--9.3)    7.6 (4.0--11.3)    5.7 (2.8--8.7)      0.5423
  Women                                                                                                                                                                                                                                                               
  Participants, n                                                                                                     8947                         1198                896                3799               1462              995                597                 ---
  Age standardized[c](#jah31710-note-0005){ref-type="fn"}                                                             10.2 (9.1--11.2)             14.4 (11.9--16.9)   10.1 (7.6--12.6)   10.3 (8.5--12.0)   5.4 (3.7--7.1)    9.5 (7.2--11.5)    13.4 (9.5--17.4)    \<0.001
  Adjusted for age                                                                                                    11.2 (10.1--12.3)            15.0 (12.7--17.3)   11.0 (7.9--14.1)   11.0 (9.0--13.1)   7.3 (5.6--9.1)    10.5 (8.0--12.9)   14.0 (10.2--17.8)   \<0.0001
  Adjusted for age, education                                                                                         11.3 (10.2--12.3)            14.6 (12.3--17.0)   11.0 (7.9--14.1)   11.3 (9.2--13.4)   7.3 (5.5--9.0)    10.9 (8.4--13.4)   13.6 (9.8--17.4)    \<0.0001
  Adjusted for age, education, years in US                                                                            11.2 (10.1--12.3)            13.9 (11.5--16.4)   10.7 (7.6--13.8)   11.4 (9.3--13.5)   8.4 (6.3--10.4)   10.5 (7.9--13.0)   13.0 (9.1--16.9)    0.0225
  Adjusted for age, education, years in US, health insurance                                                          11.3 (10.2--12.4)            14.0 (11.5--16.4)   10.5 (7.3--13.7)   11.5 (9.4--13.6)   8.4 (6.2--10.6)   10.7 (8.1--13.3)   13.4 (9.4--17.3)    0.0346
  Adjusted for age, education, years in US, health insurance, physical activity                                       11.2 (10.1--12.3)            13.9 (11.3--16.5)   10.7 (7.5--13.9)   11.5 (9.4--13.6)   8.4 (6.2--10.6)   10.7 (8.0--13.3)   13.3 (9.3--17.3)    0.0371

CVD indicates cardiovascular disease; US, United States.

All values (except n) were weighted for survey design and nonresponse.

Low‐risk status described under "Definition of Risk Factors."

Age standardized to the 2010 US population.

![Age‐adjusted prevalence of cardiovascular disease risk profiles by Hispanic/Latino background in men (A) and in women (B). Risk profile details are described under "Definition of Risk Factors." All values were weighted for survey design and nonresponse and adjusted for age. BMI indicates body mass index; BP, blood pressure; LR, low risk; RF, risk factor.](JAH3-5-e003929-g001){#jah31710-fig-0001}

###### 

Age‐Stratified Prevalence of Low CVD Risk Status by Sex and Hispanic/Latino Background

  Age Group, y   Prevalence of Low‐Risk Status[a](#jah31710-note-0006){ref-type="fn"}, [b](#jah31710-note-0007){ref-type="fn"}                                                                
  -------------- --------------------------------------------------------------------------------------------------------------- ----------- ----------- ------------ ----------- ----------- -----------
  Men                                                                                                                                                                                         
  18--44         202 (8.1)                                                                                                       26 (7.3)    16 (8.0)    73 (7.2)     37 (10.2)   30 (9.4)    20 (10.7)
  45--74         34 (1.4)                                                                                                        7 (0.6)     2 (1.0)     10 (1.5)     7 (1.6)     5 (1.3)     3 (0.9)
  Women                                                                                                                                                                                       
  18--44         550 (17.9)                                                                                                      74 (23.3)   67 (18.5)   258 (17.9)   44 (10.0)   65 (17.2)   42 (21.8)
  45--74         73 (1.2)                                                                                                        7 (1.0)     8 (1.5)     38 (1.8)     5 (0.3)     7 (0.9)     8 (1.5)

CVD indicates cardiovascular disease.

All values (except n) were weighted for survey design and nonresponse.

Low‐risk status is described under "Definition of Risk Factors."

Among women, age‐adjusted LR prevalence was also uniformly low overall (11.2%), whereas age‐standardized prevalence was 10.2% (Table [1](#jah31710-tbl-0001){ref-type="table-wrap"}). Age‐adjusted LR prevalence ranged from 7.3% (Puerto Rican women) to 15.0% (Cuban women). Adjustment for educational attainment did not alter the findings. LR prevalence among women aged 18 to 44 years ranged from 10.0% (Puerto Rican women) to 23.3% (Cuban women), whereas among those aged 45 to 74 years, LR prevalence ranged from 0.3% to 1.8% (Table [2](#jah31710-tbl-0002){ref-type="table-wrap"}).

Lack of current smoking was the most predominant favorable risk factor among both men (74.1%) and women (83.9%). Slightly more than half of men (51.3%) also had favorable serum cholesterol levels, and a sizeable proportion of women had ideal glucose levels (59.8%), ideal BP (58.9%), and ideal serum cholesterol levels (54.7%), with no medication use for any of these risk factors; however, less than a fourth of men and women had a favorable BMI. Men with Mexican backgrounds had the lowest rates of favorable levels of serum glucose, and BMI and those of Puerto Rican background the lowest rates of not currently smoking. Among women, those with Puerto Rican backgrounds had the lowest rates of favorable BP levels, BMI, and not currently smoking (Table [3](#jah31710-tbl-0003){ref-type="table-wrap"}).

###### 

Adjusted Prevalence of Low CVD Risk Status and Components of LR by Sex and Hispanic/Latino Background

  LR Status[a](#jah31710-note-0009){ref-type="fn"} and Individual Favorable Risk Factors                                                 Hispanic/Latino Background                                                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ----------
  All                                                                                                                                                                                                                                                                                         
  Participants, n                                                                                                                        14 757                       2238                1369                6035                2481                1624                1010                
  LR status                                                                                                                              8.4 (7.6--9.1)               10.4 (8.9--11.8)    8.0 (5.9--10.1)     7.7 (6.2--9.1)      6.8 (5.4--8.3)      8.6 (6.5--10.7)     10.2 (7.6--12.7)    0.0111
  Serum total cholesterol \<200 mg/dL and not taking cholesterol‐lowering medication                                                     41.6 (40.3--42.9)            52.1 (50.2--54.1)   56.1 (52.7--59.5)   52.1 (50.2--54.0)   57.9 (55.2--60.6)   49.2 (46.3--52.1)   50.1 (46.3--54.0)   0.0001
  Systolic BP \<120 mm Hg, diastolic BP \<80 mm Hg, and not taking antihypertensive medication                                           39.1 (37.7--40.5)            45.8 (43.8--47.8)   41.6 (38.1--45.1)   54.5 (52.6--56.4)   45.8 (43.2--48.5)   49.0 (46.3--51.8)   57.3 (53.5--61.1)   \<0.0001
  BMI \<25                                                                                                                               18.5 (17.6--19.4)            28.1 (25.9--30.3)   20.6 (17.8--23.4)   20.7 (19.0--22.4)   21.8 (19.2--24.4)   23.3 (20.3--26.4)   29.4 (25.2--33.7)   \<0.0001
  Not currently smoking                                                                                                                  71.8 (70.6--73.0)            73.3 (70.6--75.9)   88.3 (85.2--91.4)   83.0 (81.3--84.8)   67.0 (64.1--69.9)   85.8 (83.6--88.1)   86.1 (82.9--89.2)   \<0.0001
  Fasting glucose \<100 mg/dL, hemoglobin A1c \<5.7%, not taking medication for diabetes mellitus, and no history of diabetes mellitus   43.1 (41.7--44.5)            60.1 (58.0--62.1)   55.1 (51.8--58.5)   51.7 (49.6--53.8)   52.8 (50.2--55.4)   55.2 (52.2--58.3)   61.7 (58.4--65.1)   \<0.0001
  Men                                                                                                                                                                                                                                                                                         
  Participants, n                                                                                                                        5810                         1040                473                 2236                1019                629                 413                 
  LR status                                                                                                                              5.1 (4.2--6.0)               5.4 (3.8--7.0)      4.6 (2.1--7.0)      4.2 (2.7--5.8)      6.6 (4.3--8.8)      7.2 (3.6--10.7)     6.6 (3.5--9.7)      0.3853
  Serum total cholesterol \<200 mg/dL and not taking cholesterol‐lowering medication                                                     51.3 (49.6--52.9)            51.5 (48.0--55.1)   53.3 (48.1--58.6)   49.1 (46.3--52.0)   59.1 (55.3--63.0)   47.1 (41.9--52.3)   46.3 (40.5--52.1)   0.0004
  Systolic BP \<120 mm Hg, diastolic BP \<80 mm Hg, and not taking antihypertensive medication                                           39.0 (37.3--40.7)            36.3 (33.2--39.5)   25.2 (20.1--30.3)   42.4 (39.3--45.5)   40.6 (36.6--44.6)   41.1 (36.1--46.0)   49.8 (43.3--56.2)   \<0.0001
  BMI \<25                                                                                                                               22.1 (20.6--23.6)            28.1 (24.6--31.5)   17.9 (14.0--21.9)   17.3 (14.9--19.6)   25.2 (21.6--28.8)   24.4 (19.6--29.1)   24.3 (19.4--29.1)   \<0.0001
  Not currently smoking                                                                                                                  74.1 (72.3--75.8)            68.6 (65.2--72.0)   89.2 (85.0--93.3)   75.3 (72.2--78.4)   66.0 (61.8--70.1)   78.7 (74.5--82.8)   85.4 (80.4--90.4)   \<0.0001
  Fasting glucose \<100 mg/dL, hemoglobin A1c \<5.7%, not taking medication for diabetes mellitus, and no history of diabetes mellitus   49.2 (47.5--50.9)            52.2 (49.2--55.2)   48.7 (44.2--53.2)   46.7 (43.6--49.8)   48.4 (44.7--52.1)   50.9 (45.8--56.0)   56.8 (51.4--62.2)   0.0186
  Women                                                                                                                                                                                                                                                                                       
  Participants, n                                                                                                                        8947                         1198                896                 3799                1462                995                 597                 
  LR status                                                                                                                              11.2 (10.1--12.3)            15.0 (12.7--17.3)   11.0 (7.9--14.1)    11.0 (9.0--13.1)    7.3 (5.6--9.1)      10.5 (8.0--12.9)    14.0 (10.2--17.8)   \<0.0001
  Serum total cholesterol \<200 mg/dL and not taking cholesterol‐lowering medication                                                     54.7 (53.4--56.1)            52.3 (49.8--54.8)   58.3 (54.3--62.4)   55.0 (52.6--57.4)   57.1 (53.7--60.5)   51.7 (47.7--55.6)   54.3 (49.6--59.0)   0.0489
  Systolic BP \<120 mm Hg, diastolic BP \<80 mm Hg, and not taking antihypertensive medication                                           58.9 (57.4--60.3)            53.8 (51.4--56.1)   54.7 (50.5--58.8)   65.8 (63.2--68.4)   51.2 (48.1--54.2)   57.2 (54.4--60.1)   65.6 (61.3--69.8)   \<0.0001
  BMI \<25                                                                                                                               24.0 (22.5--25.5)            27.9 (24.8--30.9)   22.6 (18.5--26.7)   23.9 (21.3--26.5)   18.5 (15.6--21.4)   22.7 (19.1--26.2)   34.1 (27.9--40.3)   \<0.0001
  Not currently smoking                                                                                                                  83.9 (82.6--85.1)            77.3 (74.3--80.3)   88.8 (84.6--93.1)   89.8 (87.9--91.7)   67.6 (64.1--71.1)   92.2 (90.4--94.1)   86.9 (83.5--90.3)   \<0.0001
  Fasting glucose \<100 mg/dL, hemoglobin A1c \<5.7%, not taking medication for diabetes mellitus, and no history of diabetes mellitus   59.8 (58.4--61.1)            67.3 (65.1--69.6)   60.6 (56.5--64.7)   56.4 (54.0--58.7)   57.0 (53.6--60.4)   59.4 (56.3--62.5)   66.7 (62.6--70.7)   \<0.0001

BMI indicates body mass index; BP, blood pressure; CVD, cardiovascular disease; LR, low risk.

LR status is described under "Definition of Risk Factors."

Rates of individual favorable risk factors differed between men and women, although these sex differences varied across age strata. Prevalence of favorable serum cholesterol levels was 10.8 percentage points higher for women aged 18 to 44 years compared with men of the same age range. Conversely, among those aged 45 to 74 years, prevalence of favorable serum cholesterol levels was 9.14 percentage points lower in women compared with men. Findings were similar for favorable BMI levels, although the magnitudes of the sex differences in LR prevalence in each age strata were lower (4.79 percentage points higher for women versus men aged 18--44 years and 3.31 percentage points lower for women versus men aged 45--74 years). Rates of no current smoking, ideal glucose levels, and particularly ideal BP levels were markedly higher in women aged 18 to 44 years (about 11--28 percentage points higher) compared with men in the same age range. Although rates of these favorable risk factors were also higher among women (versus men) aged 45 to 74 years (by about 3--8 percentage points), the magnitude of differences was much lower (data not shown).

Association of LR Status With Measures of Acculturation {#jah31710-sec-0014}
-------------------------------------------------------

Among women, being less acculturated was positively associated with having a LR profile versus not (ie, all others) (Table [4](#jah31710-tbl-0004){ref-type="table-wrap"}). In age‐adjusted analyses, for example, women who were foreign born (versus US born), who had resided in the United States \<10 years (versus ≥10 years; among all participants), and who preferred the use of Spanish to English had 1.64, 1.96, and 1.54 times higher odds, respectively, of being LR. Women with SASH language subscale scores \<3 versus ≥3 (ie, lower versus higher acculturation) had 1.58 times higher odds of being LR compared with not LR. In contrast, the odds of being LR did not differ by levels of SASH social subscale scores. Among men, no significant associations were found between SASH scores or proxy measures of acculturation and LR prevalence (Table [4](#jah31710-tbl-0004){ref-type="table-wrap"}). Analyses adjusted for family history of coronary heart disease and for Hispanic/Latino background, health insurance status, and field center yielded similar results (data not shown). Additional sensitivity analyses examining the age‐adjusted association of LR status with measures of acculturation across educational attainment strata revealed no significant associations among men. Although associations between measures of acculturation and LR status differed across strata of educational attainment for women, effect estimates were unstable, given the small numbers in the cells (data not shown).

###### 

Adjusted Associations of LR Status With Measures of Acculturation by Sex

  Measure of Acculturation[b](#jah31710-note-0012){ref-type="fn"}   LR (Reference: Not LR)[a](#jah31710-note-0011){ref-type="fn"}   
  ----------------------------------------------------------------- --------------------------------------------------------------- -------------------
  Men                                                                                                                               
  Foreign born                                                      1.03 (0.73--1.46)                                               1.09 (0.77--1.54)
  Residence in US \<10 years                                        0.87 (0.61--1.23)                                               0.88 (0.62--1.25)
  Prefer Spanish                                                    0.84 (0.57--1.23)                                               0.88 (0.61--1.29)
  Age at immigration, y                                             0.99 (0.96--1.01)                                               0.99 (0.96--1.01)
  Age ≥25 years at immigration                                      1.19 (0.65--2.19)                                               1.14 (0.62--2.09)
  SASH language subscale (low; ie, \<3)                             0.83 (0.57--1.21)                                               0.87 (0.60--1.27)
  SASH social subscale (low; ie, \<3)                               0.77 (0.52--1.15)                                               0.79 (0.53--1.19)
  Women                                                                                                                             
  Foreign born                                                      1.64 (1.24--2.17)                                               1.69 (1.28--2.24)
  Residence in US \<10 years                                        1.96 (1.49--2.58)                                               2.01 (1.54--2.63)
  Prefer Spanish                                                    1.54 (1.14--2.08)                                               1.71 (1.27--2.30)
  Age at immigration, y                                             1.05 (1.02--1.07)                                               1.05 (1.02--1.07)
  Age ≥25 years at immigration                                      2.04 (1.39--2.99)                                               1.88 (1.27--2.78)
  SASH language subscale (low; ie, \<3)                             1.58 (1.19--2.11)                                               1.71 (1.29--2.28)
  SASH social subscale (low; ie, \<3)                               1.27 (0.92--1.76)                                               1.34 (0.98--1.83)

LR indicates low risk; OR, odds ratio; SASH, Short Acculturation Scale for Hispanics; US, United States.

LR status is described under "Definition of Risk Factors."

Models constructed comparing foreign‐born vs US‐born participants, residence in US \<10 years vs ≥10 years, Spanish language preference vs English, and SASH scores \<3 vs ≥3. Variables were entered into the model individually.

All values (except n) were weighted for survey design and nonresponse.

Characteristics of LR Participants Compared With Others {#jah31710-sec-0015}
-------------------------------------------------------

Tables [5](#jah31710-tbl-0005){ref-type="table-wrap"} and [6](#jah31710-tbl-0006){ref-type="table-wrap"} provide age‐adjusted demographic, socioeconomic, and sociocultural characteristics of Hispanic/Latino men and women across CVD risk groups. LR men and women were significantly younger than others. After adjustment for age, LR adults had the highest mean educational attainment, with differences across groups significant for women but not for men. In addition, the proportion of participants with an annual family income \<\$20 000 was lowest among LR men and women compared with others, with significant differences for women.

###### 

Descriptive Characteristics of HCHS/SOL Participants, All and by Risk Status---Men

  Characteristic[a](#jah31710-note-0016){ref-type="fn"}   CVD Risk Status,[b](#jah31710-note-0017){ref-type="fn"} Mean or % (95% CI)   *P* Value                                                                                     
  ------------------------------------------------------- ---------------------------------------------------------------------------- ----------------------- ----------------------- ---------------------- ---------------------- ----------
  Participants, n                                         5810                                                                         236                     1347                    1977                   2250                   
  Age                                                     40.4 (39.8--41.0)                                                            27.3 (25.8--28.7)       35.6 (34.7--36.4)       38.7 (37.8--39.7)      47.9 (47.0--48.8)      \<0.0001
  Education (%)                                                                                                                                                                                                                      
  Less than high school                                   32.6 (30.7--34.5)                                                            28.2 (21.9--34.5)       30.6 (26.8--34.4)       33.6 (30.7--36.5)      33.5 (30.3--36.8)      0.3674
  High school graduate                                    30.5 (28.8--32.2)                                                            35.5 (27.9--43.2)       30.2 (26.7--33.7)       29.7 (26.7--32.7)      30.5 (27.7--33.3)      0.5770
  Beyond high school                                      36.9 (34.8--39.0)                                                            36.3 (27.6--45.0)       39.2 (35.4--42.9)       36.7 (33.3--40.0)      36.0 (32.8--39.1)      0.5593
  Years of education                                      11.8 (11.6--12.0)                                                            12.1 (11.6--12.7)       12.0 (11.6--12.3)       11.8 (11.6--12.0)      11.6 (11.4--11.8)      0.3059
  Annual family income (%)                                                                                                                                                                                                           
  \<\$20 000                                              38.4 (36.1--40.8)                                                            32.9 (24.8--40.9)       35.7 (31.9--39.5)       38.3 (35.1--41.5)      41.5 (38.0--44.9)      0.0568
  \$20 000--50 000                                        39.5 (37.6--41.4)                                                            44.4 (35.7--53.1)       38.9 (35.2--42.6)       37.7 (34.6--40.8)      41.2 (38.1--44.4)      0.3123
  \>\$50 000                                              14.7 (12.6--16.9)                                                            10.9 (4.9--17.0)        18.3 (13.7--22.9)       16.1 (13.3--18.9)      11.2 (9.0--13.5)       0.0040
  Not reported                                            7.3 (6.3--8.4)                                                               11.8 (6.9--16.7)        7.1 (5.0--9.2)          7.9 (6.3--9.5)         6.1 (4.7--7.4)         0.0738
  Marital status (%)                                                                                                                                                                                                                 
  Single                                                  36.2 (34.4--37.9)                                                            46.1 (39.5--52.7)       32.9 (29.4--36.4)       36.2 (33.3--39.2)      36.4 (33.7--39.0)      0.0048
  Married/living with partner                             52.2 (50.1--54.2)                                                            42.8 (35.3--50.3)       56.3 (52.5--60.0)       52.0 (48.9--55.1)      52.2 (49.1--55.2)      0.0049
  Separated/divorced/widowed                              11.6 (10.6--12.7)                                                            11.1 (8.3--13.8)        10.8 (9.1--12.6)        11.8 (9.9--13.7)       11.5 (9.6--13.4)       0.8848
  US born (%)                                             22.6 (20.7--24.6)                                                            24.3 (17.1--31.6)       18.4 (14.6--22.3)       23.1 (20.3--26.0)      24.7 (22.0--27.5)      0.0481
  Residence in US ≥10 years                               72.2 (69.9--74.4)                                                            75.0 (68.0--82.0)       66.5 (62.9--70.2)       71.3 (68.2--74.3)      76.8 (73.5--80.0)      \<0.0001
  Immigrant generation (%)                                                                                                                                                                                                           
  First                                                   75.7 (73.6--77.7)                                                            73.6 (66.2--80.9)       80.6 (76.7--84.4)       75.4 (72.5--78.2)      73.0 (69.9--76.0)      0.0140
  Second or higher                                        24.3 (22.3--26.4)                                                            26.4 (19.1--33.8)       19.4 (15.6--23.3)       24.6 (21.8--27.5)      27.0 (24.0--30.1)      0.0140
  Age at immigration (%)                                                                                                                                                                                                             
  ≤10 years                                               11.3 (10.0--12.5)                                                            21.4 (12.9--29.9)       7.9 (5.5--10.2)         10.6 (8.7--12.5)       12.9 (10.6--15.2)      0.0005
  11--24 years                                            41.6 (39.4--43.8)                                                            33.6 (23.9--43.3)       41.5 (37.9--45.1)       43.3 (40.0--46.7)      41.4 (37.5--45.3)      0.3107
  25 years                                                47.1 (44.7--49.5)                                                            44.9 (36.4--53.5)       50.6 (46.9--54.3)       46.1 (42.8--49.3)      45.6 (41.7--49.6)      0.1059
  Age at immigration, y                                   25.4 (24.8--26.0)                                                            24.4 (22.7--26.1)       26.9 (26.0--27.8)       25.3 (24.5--26.0)      24.7 (23.8--25.7)      0.0001
  Language preference (%)                                                                                                                                                                                                            
  Spanish                                                 75.3 (73.2--77.5)                                                            69.8 (61.3--78.3)       81.6 (78.3--84.8)       75.6 (72.6--78.6)      71.7 (68.6--74.8)      \<0.0001
  English                                                 24.7 (22.5--26.8)                                                            30.2 (21.7--38.7)       18.4 (15.2--21.7)       24.4 (21.4--27.4)      28.3 (25.2--31.4)      \<0.0001
  SASH language subscale                                                                                                                                                                                                             
  Low (1 to \<3)                                          76.4 (74.5--78.3)                                                            71.0 (62.7--79.4)       82.0 (78.6--85.3)       76.6 (73.8--79.4)      73.2 (70.1--76.2)      0.0012
  High (≥3)                                               23.6 (21.7--25.5)                                                            29.0 (20.6--37.3)       18.0 (14.7--21.4)       23.4 (20.6--26.2)      26.8 (23.8--29.9)      0.0012
  SASH language subscale score                            2.0 (2.0--2.1)                                                               2.2 (2.0--2.4)          1.9 (1.8--2.0)          2.0 (2.0--2.1)         2.1 (2.0--2.2)         0.0012
  SASH social subscale                                                                                                                                                                                                               
  Low (1 to \<3)                                          81.7 (80.1--83.2)                                                            76.7 (69.1--84.4)       83.8 (81.1--86.6)       81.4 (78.8--84.1)      81.2 (78.7--83.8)      0.2597
  High (≥3)                                               18.3 (16.8--19.9)                                                            23.3 (15.6--30.9)       16.2 (13.4--18.9)       18.6 (15.9--21.2)      18.8 (16.2--21.3)      0.2597
  SASH social subscale score                              2.3 (2.2--2.3)                                                               2.3 (2.3--2.4)          2.2 (2.2--2.3)          2.3 (2.2--2.3)         2.3 (2.2--2.3)         0.1204
  Health insurance (%)                                    47.3 (45.0--49.5)                                                            59.9 (51.8--68.0)       47.1 (42.4--51.8)       45.7 (42.5--49.0)      47.2 (44.2--50.3)      0.0102
  Total physical activity, MET‐min/day                    929.8 (879.6--979.9)                                                         836.5 (611.6--1061.5)   972.1 (867.7--1076.6)   907.1 (832.9--981.2)   921.9 (844.8--999.0)   0.5647

0 RF indicates, no adverse but ≥1 unfavorable risk factor; 1 RF, any single adverse risk factor; 2+ RF, ≥2 adverse risk factors; BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; LR, low risk; MET, metabolic equivalent; RF, risk factor; SASH, Short Acculturation Scale for Hispanics; US, United States.

All values (except n) were weighted for survey design and nonresponse. All variables (except age) were adjusted for age.

Risk status details are described under "Definition of Risk Factors."

###### 

Descriptive Characteristics of HCHS/SOL Participants, All and by Risk Status---Women

  Characteristic[a](#jah31710-note-0019){ref-type="fn"}   CVD Risk Status,[b](#jah31710-note-0020){ref-type="fn"} Mean or % (95% CI)   *P* Value                                                                                   
  ------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------
  Participants, n                                         8947                                                                         623                    1851                   3059                   3414                   
  Age                                                     42.1 (41.5--42.6)                                                            27.6 (26.7--28.5)      37.0 (36.1--38.0)      40.6 (39.8--41.3)      52.1 (51.1--53.0)      \<0.0001
  Education (%)                                                                                                                                                                                                                    
  Less than high school                                   32.8 (31.0--34.6)                                                            22.1 (17.9--26.3)      31.3 (27.4--35.1)      32.6 (30.1--35.1)      37.9 (34.8--41.1)      \<0.0001
  High school graduate                                    27.1 (25.7--28.6)                                                            25.6 (20.5--30.8)      24.2 (20.9--27.4)      27.5 (25.1--29.9)      29.4 (26.4--32.4)      0.1763
  Beyond high school                                      40.1 (38.1--42.1)                                                            52.3 (46.1--58.4)      44.5 (40.6--48.5)      39.9 (37.3--42.6)      32.7 (29.8--35.5)      \<0.0001
  Years of education                                      11.7 (11.6--11.9)                                                            12.5 (12.1--12.9)      12.0 (11.7--12.4)      11.8 (11.6--12.0)      11.1 (10.9--11.3)      \<0.0001
  Annual family income (%)                                                                                                                                                                                                         
  \<\$20 000                                              45.8 (44.0--47.5)                                                            35.4 (30.0--40.8)      43.2 (39.5--46.8)      46.4 (43.7--49.1)      51.1 (47.6--54.5)      \<0.0001
  \$20 000--50 000                                        34.3 (32.6--35.9)                                                            38.9 (33.9--43.9)      35.1 (31.8--38.3)      35.3 (32.7--37.8)      31.0 (28.1--33.8)      0.0373
  \>\$50 000                                              8.8 (7.5--10.0)                                                              10.0 (6.7--13.4)       11.7 (8.6--14.8)       9.6 (7.8--11.3)        5.0 (3.4--6.6)         0.0003
  Not reported                                            11.2 (10.2--12.3)                                                            15.7 (11.8--19.6)      10.1 (8.1--12.0)       8.8 (7.4--10.2)        12.9 (11.3--14.6)      \<0.0001
  Marital status                                                                                                                                                                                                                   
  Single                                                  31.9 (30.4--33.4)                                                            35.5 (30.5--40.4)      25.5 (22.5--28.5)      29.0 (26.6--31.4)      38.2 (35.2--41.2)      \<0.0001
  Married/living with partner                             47.7 (45.9--49.5)                                                            42.2 (36.3--48.1)      54.9 (51.4--58.5)      51.9 (49.0--54.8)      40.8 (37.7--43.9)      \<0.0001
  Separated/divorced/widowed                              20.4 (19.1--21.6)                                                            22.4 (19.2--25.5)      19.5 (17.1--22.0)      19.1 (17.1--21.1)      21.0 (19.0--23.0)      0.1745
  US born                                                 20.1 (18.6--21.7)                                                            13.5 (8.9--18.2)       14.3 (11.7--16.9)      19.5 (17.3--21.7)      27.7 (24.9--30.4)      \<0.0001
  Residence in US ≥10 years                               70.4 (68.2--72.6)                                                            57.6 (51.4--63.7)      67.7 (64.2--71.2)      72.7 (69.9--75.5)      74.9 (71.8--78.0)      \<0.0001
  Immigrant generation (%)                                                                                                                                                                                                         
  First                                                   78.6 (77.0--80.2)                                                            85.0 (80.2--89.7)      84.7 (82.1--87.4)      79.0 (76.7--81.3)      71.2 (68.3--74.0)      \<0.0001
  Second or higher                                        21.4 (19.8--23.0)                                                            15.0 (10.3--19.8)      15.3 (12.6--17.9)      21.0 (18.7--23.3)      28.8 (26.0--31.7)      \<0.0001
  Age at immigration (%)                                                                                                                                                                                                           
  ≤10 years                                               13.3 (11.8--14.7)                                                            10.7 (5.7--15.7)       10.3 (7.6--13.0)       13.2 (10.7--15.7)      17.4 (14.5--20.3)      0.0017
  11--24 years                                            37.8 (36.1--39.5)                                                            36.8 (30.9--42.6)      35.1 (31.7--38.5)      37.6 (34.8--40.4)      40.5 (37.2--43.7)      0.1229
  25 years                                                49.0 (47.0--50.9)                                                            52.6 (46.9--58.3)      54.6 (51.1--58.2)      49.2 (46.2--52.3)      42.2 (38.7--45.6)      \<0.0001
  Age at immigration                                      25.7 (25.1--26.3)                                                            27.6 (26.3--28.9)      26.5 (25.6--27.3)      25.2 (24.3--26.1)      24.5 (23.5--25.6)      0.0003
  Language preference                                                                                                                                                                                                              
  Spanish                                                 77.4 (75.6--79.3)                                                            83.9 (78.6--89.2)      84.9 (82.2--87.6)      76.7 (73.8--79.6)      70.3 (66.8--73.7)      \<0.0001
  English                                                 22.6 (20.7--24.4)                                                            16.1 (10.8--21.4)      15.1 (12.4--17.8)      23.3 (20.4--26.2)      29.7 (26.3--33.2)      \<0.0001
  SASH language subscale                                                                                                                                                                                                           
  Low (1 to \<3)                                          78.7 (76.9--80.5)                                                            84.8 (80.0--89.6)      85.4 (82.6--88.2)      78.3 (75.5--81.0)      71.8 (68.6--75.1)      \<0.0001
  High (≥3)                                               21.3 (19.5--23.1)                                                            15.2 (10.4--20.0)      14.6 (11.8--17.4)      21.7 (19.0--24.5)      28.2 (24.9--31.4)      \<0.0001
  SASH language subscale score                            1.9 (1.8--1.9)                                                               1.7 (1.6--1.9)         1.8 (1.7--1.8)         1.9 (1.8--2.0)         2.1 (2.0--2.2)         \<0.0001
  SASH social subscale                                                                                                                                                                                                             
  Low (1 to \<3)                                          84.0 (82.7--85.3)                                                            86.4 (82.2--90.5)      86.6 (83.8--89.4)      84.5 (82.4--86.5)      80.7 (77.6--83.8)      0.0695
  High (≥3)                                               16.0 (14.7--17.3)                                                            13.6 (9.5--17.8)       13.4 (10.6--16.2)      15.5 (13.5--17.6)      19.3 (16.2--22.4)      0.0695
  SASH social subscale score                              2.2 (2.2--2.2)                                                               2.2 (2.1--2.2)         2.2 (2.1--2.2)         2.2 (2.1--2.2)         2.2 (2.2--2.3)         0.1815
  Health insurance (%)                                    51.8 (49.8--53.9)                                                            50.9 (44.9--56.8)      53.0 (49.4--56.7)      47.8 (44.8--50.8)      55.9 (52.6--59.2)      0.0009
  Total physical activity, MET‐min/day                    437.5 (411.0--464.0)                                                         414.4 (329.9--498.9)   401.6 (359.9--443.3)   446.6 (402.9--490.3)   447.1 (366.7--527.5)   0.4932

0 RF indicates, no adverse but ≥1 unfavorable risk factor; 1 RF, any single adverse risk factor; 2+ RF, ≥2 adverse risk factors; BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; LR, low risk; MET, metabolic equivalent; RF, risk factor; SASH, Short Acculturation Scale for Hispanics; US, United States.

All values (except n) were weighted for survey design and nonresponse. All variables (except age) were adjusted for age.

Risk status details are described under "Definition of Risk Factors."

Among women, those who were LR were, in general, less acculturated than others. LR women, for example, had the lowest age‐adjusted rates of being US born and of having resided in the United States for ≥10 years compared with others (*P*\<0.0001). Foreign‐born LR women also had the highest mean age at immigration (27.6  versus 24.5 years for those with LR and with ≥2 adverse risk factors, respectively; *P*=0.0003). In contrast, among men, those who were LR were more acculturated; they were least likely to prefer the use of Spanish compared with others and had among the highest proportions of those who were US born or who had resided in the United States for ≥10 years in age‐adjusted analyses. Rates of health insurance were higher among LR men compared with others (59.9%; *P*=0.0102); conversely, among women, the highest rates of health insurance were reported by those who had ≥2 adverse risk factors (55.9%; *P*=0.0009).

Tables [7](#jah31710-tbl-0007){ref-type="table-wrap"} and [8](#jah31710-tbl-0008){ref-type="table-wrap"} provide the prevalence and mean levels of CVD risk factors by CVD risk status for men and women, respectively.

###### 

Prevalence and Mean Levels of CVD Risk Factors for Men by CVD Risk Profiles

  CVD Risk Factors[a](#jah31710-note-0022){ref-type="fn"}             CVD Risk Status,[b](#jah31710-note-0023){ref-type="fn"} Mean or % (95% CI)   *P* Value                                                            
  ------------------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------- ---------------------- ---------------------- ----------
  Participants, n                                                     236                                                                          1347                   1977                   2250                   
  Total cholesterol, mg/dL                                            159.4 (155.1--163.7)                                                         186.3 (184.0--188.7)   194.1 (191.6--196.6)   209.4 (206.1--212.8)   \<0.0001
  LDL cholesterol, mg/dL                                              93.0 (89.2--96.9)                                                            116.3 (114.2--118.4)   122.2 (120.0--124.3)   130.9 (127.8--134.1)   \<0.0001
  HDL cholesterol, mg/dL                                              49.2 (47.3--51.2)                                                            46.3 (45.5--47.0)      44.8 (44.1--45.4)      43.4 (42.6--44.1)      \<0.0001
  Triglycerides, mg/dL                                                86.5 (77.2--95.9)                                                            120.8 (114.3--127.3)   141.0 (135.3--146.8)   188.0 (177.7--198.2)   \<0.0001
  Elevated triglycerides (%)[c](#jah31710-note-0024){ref-type="fn"}   9.8 (5.2--14.4)                                                              22.3 (19.2--25.4)      32.3 (29.7--34.9)      50.6 (47.5--53.8)      \<0.0001
  Systolic BP, mm Hg                                                  114.6 (113.5--115.7)                                                         120.6 (119.8--121.4)   122.1 (121.5--122.8)   129.1 (128.1--130.2)   \<0.0001
  Diastolic BP, mm Hg                                                 63.7 (62.5--64.9)                                                            70.7 (70.0--71.4)      73.2 (72.6--73.7)      78.1 (77.3--78.9)      \<0.0001
  BMI category (%)                                                                                                                                                                                                      
  Underweight                                                         8.5 (4.5--12.5)                                                              0.6 (0.1--1.1)         0.6 (0.2--1.0)         0.3 (0.1--0.6)         0.0001
  Normal                                                              91.5 (87.3--95.7)                                                            23.3 (20.4--26.2)      22.4 (19.5--25.3)      8.1 (6.6--9.5)         \<0.0001
  Overweight                                                          ---                                                                          80.2 (77.2--83.1)      40.1 (37.4--42.8)      20.6 (18.0--23.2)      \<0.0001
  Obese                                                               ---                                                                          ---                    36.9 (34.0--39.8)      71.0 (68.3--73.8)      \<0.0001
  BMI                                                                 21.0 (20.6--21.5)                                                            26.0 (25.8--26.2)      28.8 (28.5--29.2)      32.1 (31.8--32.4)      \<0.0001
  Fasting glucose, mg/dL                                              93.7 (92.5--95.0)                                                            96.5 (95.8--97.2)      98.8 (98.0--99.7)      117.5 (114.7--120.3)   \<0.0001
  Smoking status (%)                                                                                                                                                                                                    
  Never smoker                                                        87.2 (82.6--91.8)                                                            73.9 (70.7--77.1)      46.5 (43.3--49.7)      35.1 (31.8--38.3)      \<0.0001
  Former smoker                                                       21.5 (17.1--25.9)                                                            29.6 (26.6--32.7)      21.3 (19.3--23.3)      19.3 (16.8--21.8)      \<0.0001
  Current smoker                                                      ---                                                                          ---                    32.2 (29.3--35.1)      45.7 (42.3--49.1)      \<0.0001
  Waist/hip ratio                                                     0.88 (0.87--0.89)                                                            0.92 (0.92--0.93)      0.94 (0.94--0.95)      0.97 (0.97--0.98)      \<0.0001
  Central obesity (%)[d](#jah31710-note-0025){ref-type="fn"}          30.8 (25.0--36.6)                                                            63.4 (59.9--67.0)      77.3 (74.6--80.0)      87.2 (85.3--89.1)      \<0.0001
  Waist circumference, cm                                             80.2 (79.0--81.3)                                                            91.1 (90.6--91.7)      98.1 (97.2--99.0)      106.2 (105.5--107.0)   \<0.0001
  Waist circumference \>102 cm                                        ---                                                                          5.9 (4.3--7.5)         34.5 (31.6--37.4)      62.9 (59.7--66.0)      \<0.0001

0 RF indicates, no adverse but ≥1 unfavorable risk factor; 1 RF, any single adverse risk factor; 2+ RF, ≥2 adverse risk factors; BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; LR, low risk; RF, risk factor; ---, cannot be estimated.

All values (except n) were weighted for survey design and nonresponse.

Risk status details are described under "Definition of Risk Factors." To convert total, LDL, and HDL cholesterol to mmol/L, multiply by 0.0259; to convert glucose to mmol/L, multiply by 0.0555.

Elevated triglyceride levels were defined as triglycerides ≥150 mg/dL.

Central obesity was defined as waist/hip ratio ≥0.85 for women, ≥0.90 for men.

###### 

Prevalence and Mean Levels of CVD Risk Factors for Women by CVD Risk Profiles

  CVD Risk Factors[a](#jah31710-note-0027){ref-type="fn"}             CVD Risk Status,[b](#jah31710-note-0028){ref-type="fn"} Mean or % (95% CI)   *P* Value                                                            
  ------------------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------- ---------------------- ---------------------- ----------
  Participants, n                                                     623                                                                          1851                   3059                   3414                   
  Total cholesterol, mg/dL                                            170.4 (168.0--172.9)                                                         190.4 (188.4--192.4)   193.7 (191.9--195.6)   205.0 (202.6--207.5)   \<0.0001
  LDL cholesterol, mg/dL                                              96.7 (94.5--98.9)                                                            115.2 (113.5--116.8)   119.2 (117.6--120.8)   128.1 (125.9--130.2)   \<0.0001
  HDL cholesterol, mg/dL                                              58.6 (57.2--60.0)                                                            54.5 (53.6--55.4)      50.8 (50.1--51.5)      48.3 (47.6--49.1)      \<0.0001
  Triglycerides, mg/dL                                                76.0 (72.7--79.3)                                                            103.9 (100.5--107.2)   118.8 (115.3--122.3)   144.6 (139.5--149.8)   \<0.0001
  Elevated triglycerides (%)[c](#jah31710-note-0029){ref-type="fn"}   6.2 (4.4--8.0)                                                               15.5 (13.2--17.9)      22.6 (20.5--24.7)      36.6 (33.8--39.3)      \<0.0001
  Systolic BP, mm Hg                                                  110.9 (109.8--112.0)                                                         112.9 (112.2--113.7)   114.3 (113.7--114.8)   122.6 (121.6--123.6)   \<0.0001
  Diastolic BP, mm Hg                                                 63.4 (62.6--64.1)                                                            67.8 (67.2--68.4)      70.9 (70.4--71.4)      75.5 (74.8--76.2)      \<0.0001
  BMI category (%)                                                                                                                                                                                                      
  Underweight                                                         7.9 (4.9--10.9)                                                              0.2 (0.0--0.5)         1.2 (0.4--2.0)         0.5 (0.1--0.9)         \<0.0001
  Normal                                                              94.1 (90.9--97.4)                                                            22.5 (19.7--25.2)      14.8 (12.9--16.7)      5.1 (3.7--6.5)         \<0.0001
  Overweight                                                          ---                                                                          80.2 (77.4--82.9)      27.6 (25.4--29.7)      15.4 (13.3--17.5)      \<0.0001
  Obese                                                               ---                                                                          ---                    56.4 (53.9--59.0)      79.0 (76.6--81.4)      \<0.0001
  BMI                                                                 20.9 (20.6--21.2)                                                            26.1 (25.9--26.3)      30.9 (30.6--31.3)      34.3 (33.8--34.7)      \<0.0001
  Fasting glucose, mg/dL                                              89.8 (88.8--90.9)                                                            91.2 (90.7--91.8)      94.7 (93.5--96.0)      113.2 (110.4--115.9)   \<0.0001
  Smoking status (%)                                                                                                                                                                                                    
  Never smoker                                                        96.1 (92.7--99.5)                                                            90.5 (88.2--92.7)      68.1 (65.5--70.7)      51.4 (48.3--54.4)      \<0.0001
  Former smoker                                                       12.0 (8.9--15.1)                                                             12.0 (9.9--14.2)       14.0 (12.4--15.6)      11.3 (9.5--13.0)       0.1196
  Current smoker                                                      ---                                                                          ---                    17.9 (15.8--20.0)      37.4 (34.3--40.4)      \<0.0001
  Waist/hip ratio                                                     0.85 (0.84--0.85)                                                            0.87 (0.87--0.88)      0.90 (0.90--0.90)      0.92 (0.91--0.92)      \<0.0001
  Central obesity (%)[d](#jah31710-note-0030){ref-type="fn"}          43.4 (38.5--48.2)                                                            65.9 (62.6--69.2)      77.4 (75.0--79.7)      83.0 (80.6--85.4)      \<0.0001
  Waist circumference, cm                                             77.9 (77.2--78.7)                                                            88.8 (88.1--89.5)      98.7 (98.0--99.4)      106.0 (105.1--106.9)   \<0.0001
  Waist circumference \>88 cm                                         13.2 (9.8--16.6)                                                             61.0 (57.7--64.2)      81.3 (79.3--83.4)      91.6 (89.6--93.6)      \<0.0001

0 RF indicates, no adverse but ≥1 unfavorable risk factor; 1 RF, any single adverse risk factor; 2+ RF, ≥2 adverse risk factors; BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; LR, low risk; RF, risk factor; ---, cannot be estimated.

All values (except n) were weighted for survey design and nonresponse.

Risk status details are described under "Definition of Risk Factors." To convert total, LDL, and HDL cholesterol to mmol/L, multiply by 0.0259; to convert glucose to mmol/L, multiply by 0.0555.

Elevated triglyceride levels were defined as triglycerides ≥150 mg/dL.

Central obesity was defined as waist/hip ratio ≥0.85 for women, ≥0.90 for men.

Unfavorable or Borderline Risk Status {#jah31710-sec-0016}
-------------------------------------

Age‐adjusted prevalence of unfavorable or borderline risk (ie, neither LR nor high risk) was 24.9% and 24.1% among men and women, respectively, and ranged from 20.1% (Puerto Rican background) to 36.3% (South American background) among men ([Figure](#jah31710-fig-0001){ref-type="fig"} --- Panel A) and from 14.6% (Puerto Rican background) to 33.1% (South American background) among women ([Figure](#jah31710-fig-0001){ref-type="fig"} --- Panel B). The majority of participants with unfavorable risk status were overweight (80.2% for both men and women). Furthermore, about 51.7% of men and 26.5% of women with unfavorable risk status had unfavorable BP levels; 38.2% and 40.6%, respectively, had unfavorable cholesterol levels; and 38.6% and 27.5%, respectively, had unfavorable glucose levels (data not shown).

Men characterized as being at unfavorable risk were, in general, less acculturated than other men. Overall, 81.6% of men at unfavorable risk reported preferring Spanish (versus English), and 66.5% had lived in the United States for ≥10 years compared with 71.7% and 76.8%, respectively, of men with ≥2 adverse risk factors (*P*\<0.0001) (Table [5](#jah31710-tbl-0005){ref-type="table-wrap"}).

Discussion {#jah31710-sec-0017}
==========

Among the adult Hispanic/Latino men and women who participated in HCHS/SOL, age‐adjusted prevalence of LR status was low, especially among men (5.1% of men and 11.2% of women). LR prevalence varied by Hispanic/Latino background. Among men, LR prevalence was highest among those with Central American backgrounds and lowest among those with Mexican and Dominican backgrounds, although the magnitude of variation was small (ie, only a 3--percentage point difference between the highest‐ and lowest‐prevalence groups). Among women, LR prevalence showed somewhat greater variation and was highest among those with Cuban and South American backgrounds and lowest among those with Puerto Rican backgrounds. On average, LR adults were younger and more educated (particularly women) compared with others. Being less acculturated was consistently associated with a LR profile among women, but no significant associations were seen among men. Conversely, prevalence of unfavorable or borderline CVD risk was relatively high and correlated with less acculturation among men only.

Sex differences in both the prevalence of CVD risk factors and the timing of onset of CVD have been extensively described,[18](#jah31710-bib-0018){ref-type="ref"}, [19](#jah31710-bib-0019){ref-type="ref"}, [20](#jah31710-bib-0020){ref-type="ref"} and among women, worsening of CVD risk has been noted with menopause.[20](#jah31710-bib-0020){ref-type="ref"}, [21](#jah31710-bib-0021){ref-type="ref"} Consequently, it is not surprising that in the current study, differences in LR prevalence between men and women were observed primarily at younger ages (8.1% of men and 17.9% of women), with similar low prevalence of LR among those aged 45 to 74 years (1.4% of men and 1.2% of women). Examination of individual favorable risk factors across age--sex strata suggested that changes in lipid profiles (and, to a smaller extent, BMI) may underlie changes in patterns of sex differences in LR prevalence with age. These findings may be explained by the cardioprotective effects of endogenous estrogen prior to menopause and the unfavorable effect of menopause on lipid metabolism in women.[21](#jah31710-bib-0021){ref-type="ref"}, [22](#jah31710-bib-0022){ref-type="ref"}

These findings on LR prevalence among diverse US Hispanic/Latino adults extend the findings of previous studies on adverse risk factors among US Hispanic/Latino adults[23](#jah31710-bib-0023){ref-type="ref"}, [24](#jah31710-bib-0024){ref-type="ref"}, [25](#jah31710-bib-0025){ref-type="ref"}, [26](#jah31710-bib-0026){ref-type="ref"}, [27](#jah31710-bib-0027){ref-type="ref"} and our earlier report on adverse CVD risk factors in the HCHS/SOL cohort.[1](#jah31710-bib-0001){ref-type="ref"} Previous large‐scale prospective studies have demonstrated multiple beneficial outcomes of low CVD risk status[2](#jah31710-bib-0002){ref-type="ref"}, [3](#jah31710-bib-0003){ref-type="ref"}, [4](#jah31710-bib-0004){ref-type="ref"}, [5](#jah31710-bib-0005){ref-type="ref"}, [6](#jah31710-bib-0006){ref-type="ref"}, [7](#jah31710-bib-0007){ref-type="ref"} that may exceed what would be expected from simply the absence of high CVD risk. Increasing the proportion of LR adults may yield additional health benefits beyond effective CVD prevention. Documentation of LR prevalence among this growing segment of US society is necessary to accurately estimate the magnitude of improvement in risk and future burden of disease among Hispanic/Latino adults with unfavorable or adverse levels of CVD risk factors.

National studies that have reported LR prevalence in the US Hispanic/Latino population included primarily Mexican American adults. Age‐adjusted LR prevalence (using a definition similar to ours) was 5.3% in 1999--2004 among Mexican American adults from the National Health and Nutrition Examination Survey (NHANES) compared with 8.2% for non‐Hispanic white adults (7.5% for the US population overall).[9](#jah31710-bib-0009){ref-type="ref"} An analysis of NHANES 2003--2008 data (using the AHA Life\'s Simple 7 definition) found that \<1% of adults in each major US racial/ethnic group (including Mexican American adults) had ideal levels of all 7 cardiovascular health components (5 major CVD risk factors plus physical activity and healthy diet).[28](#jah31710-bib-0028){ref-type="ref"}

The current findings of variation in LR prevalence across Hispanic/Latino backgrounds challenge the validity of extending findings based on data solely from Mexican American adults to the wider US Hispanic/Latino population. In the current study, men with Dominican and Mexican backgrounds had the lowest LR prevalence, whereas among women, those with Puerto Rican backgrounds had the lowest LR prevalence. Men with Mexican backgrounds and women with Puerto Rican backgrounds had the lowest rates of multiple favorable risk factors, explaining the particularly low prevalence of LR status in these groups; however, differences in LR prevalence by background were small, particularly among men, as was the prevalence of LR overall.

Although some previous studies have suggested that foreign‐born Mexican American adults may have more favorable risk status compared with those who were US born,[29](#jah31710-bib-0029){ref-type="ref"}, [30](#jah31710-bib-0030){ref-type="ref"} this finding has not been observed consistently.[31](#jah31710-bib-0031){ref-type="ref"} Kershaw et al reported that foreign‐born Mexican Americans adults had almost 3 times higher odds of being LR compared with US‐born Mexican American adults.[29](#jah31710-bib-0029){ref-type="ref"} Moreover, compared with US‐born Mexican American adults, the odds of being LR were \>4 times higher among foreign‐born Mexican American adults who had resided in the United States for \<10 years. In contrast, foreign‐born Mexican American adults with ≥10 years of residence in the United States had 1.61 times higher odds of being LR compared with US‐born Mexican American adults.[29](#jah31710-bib-0029){ref-type="ref"} The current findings on the association of measures of acculturation with LR status are consistent with the "healthy migrant hypothesis" (ie, that persons who choose to migrate to a different country are selectively healthier than nonmigrants),[32](#jah31710-bib-0032){ref-type="ref"} although some studies have found only weak evidence to support this hypothesis.[31](#jah31710-bib-0031){ref-type="ref"}

Acculturation is a multifaceted process that has been shown to exert parallel effects that may be both detrimental (ie, adoption of Western lifestyles) and beneficial (improved socioeconomic status and access to care). The current findings also suggest that the complex effects of acculturation may differ by sex or that as yet unmeasured factors associated with retaining Hispanic culture may also be associated with health benefits among women only. In addition, it is possible that the relatively higher LR prevalence seen among some Hispanic/Latino backgrounds (eg, Cuban and South American women) in HCHS/SOL may, to some extent, be a reflection of the comparatively lower rates of acculturation experienced by these groups.[1](#jah31710-bib-0001){ref-type="ref"} For example, the proportion of HCHS/SOL participants who lived in the United States for \>10 years was lowest among those with Cuban backgrounds (45.1%), followed by those with South American backgrounds (53.9%).[1](#jah31710-bib-0001){ref-type="ref"} Those with Cuban and South American backgrounds also included the highest proportions of adults who reported preferring the use of Spanish to English.[1](#jah31710-bib-0001){ref-type="ref"} Given the cross‐sectional nature of these analyses, it is also possible that variations seen across backgrounds are a reflection of differences in immigration patterns over time. Adjustment for proxy measures of acculturation such as duration of residence in the United States and language preference did not alter the findings. Adding to the complexity of these findings, although women with Cuban backgrounds had among the highest prevalence of LR status, they also had the highest rates of having ≥2 adverse risk factors. This result is consistent with our current findings that although this group had the highest rate of ideal BMI and among the highest rates of ideal glucose status, these participants also experienced high rates of adverse risk factors such as cigarette smoking, hypertension, and hypercholesterolemia.[1](#jah31710-bib-0001){ref-type="ref"} Further research is needed to shed light on specific aspects of diverse Hispanic/Latino cultures that may exert a health‐protective effect and to characterize the effects of acculturation by sex and ethnic background.

In light of the low rates of LR among Hispanic/Latino men and women overall, it is important to note the sizeable prevalence of unfavorable or borderline risk status: almost 1 in 4 Hispanic/Latino adult men and women overall (ranging from ≈15% of Puerto Rican women to ≈36% in South American men). These groups represent at‐risk (but not yet high‐risk) segments of the US Hispanic/Latino population that could benefit from primary preventive efforts without necessarily needing pharmaceutical intervention. These adults present an expedient and urgent opportunity to increase the proportion of the population at LR through timely implementation of interventions emphasizing overall healthy lifestyles and nutritional hygiene. In contrast, these findings on rates of LR and unfavorable risk status reveal a bleaker picture of CVD health among Hispanic/Latino adults than reported earlier. Among HCHS/SOL participants without any adverse CVD risk factors,[1](#jah31710-bib-0001){ref-type="ref"} for example, a sizeable proportion did not have favorable CVD risk profiles. Moreover, the current analyses show that among the participant groups with the highest prevalence of no adverse CVD risk factors, South American men (19.4%) and women (30.4%),[1](#jah31710-bib-0001){ref-type="ref"} only ≈7% and 14%, respectively, were LR. Consequently, the high prevalence of unfavorable risk is a sobering indication of the possibility that as the currently young Hispanic/Latino population ages, it may be burdened by even higher rates of adverse CVD risk profiles. The fact that almost half of men and more than half of women at unfavorable risk reported having no health insurance coverage underscores the importance of public health initiatives to identify persons who are at risk of developing adverse CVD risk factors.

The cross‐sectional nature of the analyses is a limitation of this study. Nevertheless, these findings are novel and of public health importance. Although the different countries in Central and South America have unique ethnic and cultural characteristics, adults with Central and South American backgrounds were grouped into these 2 broad categories. Nevertheless, HCHS/SOL data allow a level of granularity in examining the US Hispanic/Latino population by ethnic background and other characteristics that was unavailable previously. In addition, electrocardiograms may not always be accurate in evaluating a history of previous myocardial infarction because ECG changes may revert back to normal over time in a sizeable proportion of persons with a history of myocardial infarction.[33](#jah31710-bib-0033){ref-type="ref"}, [34](#jah31710-bib-0034){ref-type="ref"} Nevertheless, it is unlikely that this issue affected our estimates because adults with favorable levels of all major CVD risk factors (without use of medications to control risk factor levels) are unlikely to have had a previous myocardial infarction.

In conclusion, these findings demonstrate the low prevalence of favorable CVD risk profile among all major US Hispanic/Latino groups and the urgent need for comprehensive public health interventions and policies to lower CVD risk in this growing population. Further research is also needed to understand the mechanisms underlying the complex effects of acculturation on diverse Hispanic/Latino men and women.
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